Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Another $4 Billion Buyout

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Jun 03, 2022 9:16am

160 Views

Post# 34729178

RE:RE:Another $4 Billion Buyout

They received BTD on May 10 and got bought out today for $4.1 Billion Nice

ScienceFirst wrote:
It's not the first time I see such pattern, given that stocks can be shorted in anticipation of a buyout.

The buyout — at $76 a share — gives Bristol Myers a rival to Pfizer’s Xalkori and Roche’s Rozlytrek in ROS1-positive non-small cell lung cancer (NSCLC)

The share price for Turning Point $TPTX more than doubled on the news Friday morning. But the stock had sunk by a third since the start of the year, setting the stage for a buyout.